Quick Takeaways
- Paradigm Biocapital Advisors LP filed SCHEDULE 13G for UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN).
- Disclosed ownership: 5%.
- Date of event: 05 Aug 2025.
Paradigm Biocapital Advisors LP - 05 Aug 2025 SCHEDULE 13G Report for UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN)
- Filing Manager
- Paradigm Biocapital Advisors LP
- Reporting Manager
- Paradigm BioCapital Advisors LP
- Symbol
- URGN
- Shares outstanding
- 46,641,320 shares
- Disclosed Ownership
- 2,332,066 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G
- Filing time
- 12 Aug 2025, 16:30:35 UTC
- Date of event
- 05 Aug 2025
- Next filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Paradigm Biocapital Advisors LP disclosed 5% ownership in UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN) on 05 Aug 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Aug 2025, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Paradigm BioCapital Advisors LP | 5% | 2,332,066 | 2,332,066 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory | |
| Paradigm BioCapital Advisors GP LLC | 5% | 2,332,066 | 2,332,066 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory | |
| Senai Asefaw, M.D. | 5% | 2,332,066 | 2,332,066 | 0 | /s/ Senai Asefaw, M.D. | N/A | |
| Paradigm BioCapital International Fund Ltd. | 4.4% | 2,056,187 | 2,056,187 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory |